Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2Urogenital Neoplasms 1Unilateral Breast Neoplasms 1Neoplasms 1Microcephaly, Primary Autosomal Recessive, 6 1Breast Neoplasms 1

Interventions

pembrolizumab 4Nivolumab 4fludarabine 3aldesleukin 3Ipilimumab 3Cyclophosphamide 3vedolizumab 2enfortumab vedotin 2darolutamide 2cabozantinib 2atezolizumab 2Specimen Handling 2Riluzole 2Prednisone 2Magnetic Resonance Spectroscopy 2LDP-02 2Infliximab 2Immunoglobulin G 2Fecal Microbiota Transplantation 2Disulfides 2CTLA-4 Antigen 2CT-P13 2Biopsy 2relatlimab 1prednylidene 1palbociclib 1olaparib 1gallium 68 PSMA-11 1deltacortene 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urogenital Neoplasms × Continuous Positive Airway Pressure × 1 year × Clear all
NCT07111039 2026-05-18

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡